학술논문

Neoadjuvant Osimertinib Followed by Sequential Definitive Radiation Therapy and/or Surgery in Stage III Epidermal Growth Factor Receptor–Mutant Non-Small Cell Lung Cancer: An Open-Label, Single-Arm, Phase 2 Study
Document Type
Article
Source
In: International Journal of Radiation Oncology Biology Physics. (International Journal of Radiation Oncology Biology Physics, 1 September 2023, 117(1):105-114)
Subject
Language
English
ISSN
1879355X
03603016